Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Curcumin vs. hangover: small study tests natural remedy

NCT ID NCT07585825

Symptom relief Sponsor: OmniSolutions Laboratory Holdings Limited Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a curcumin supplement (NatureU Cheers Friends Curcumin) could reduce hangover symptoms in 12 healthy adult men. Participants took either the curcumin or a standard hangover product before drinking alcohol, then reported their hangover severity the next morning. The goal was to see if curcumin offered better relief for common hangover issues like headache, fatigue, and nausea.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

12 people

The number who actually took part.

Started

Jun 2024

Finished

Jun 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 44 years

Sex

Male participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Signed informed consent before the study and understood the study content, procedures, and possible adverse reactions. * Healthy adult man aged 20 to 48 years, inclusive. * Normal social drinking lifestyle and no alcohol dependence. * Aspartate aminotransferase and alanine aminotransferase values within two standard deviations of the normal range. * Able to maintain normal healthy routines during the study. * Able to avoid other interfering supplements for 2 weeks before and during the study. * Abstained from alcohol for 24 hours before the study. * Abstained from caffeinated beverages, including coffee, tea, and energy drinks, for 12 hours before the study. Exclusion Criteria: * Known allergy or hypersensitivity to product ingredients, including magnolia bark, milk thistle extract, turmeric, or alcohol. * History of multiple drug or food allergies. * Acute or chronic inflammatory disease, including influenza A, within the previous month. * Hypertension. * Participation in any other clinical trial within 1 month before first use of the study product. * Clinically significant gastrointestinal, renal, hepatic, neurologic, hematologic, endocrine, oncologic, pulmonary, immune, psychiatric, cardiovascular, cerebrovascular, or metabolic disease within the previous 6 months. * Acute illness or concomitant medication use from screening to first use of the study product. * Surgery within the previous 3 months. * Blood donation or major blood loss greater than 450 mL within the previous 3 months. * Difficulty swallowing. * Use of prescription or non-prescription medications affecting nutritional supplements or alcohol metabolism. * Any other factor judged by the investigator to make participation inappropriate.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Alcohol hangover are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

alcohol abuse alcohol sensitivity, acute

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Alcohol hangover Alcohol misuse

Contacts and locations

Locations

  • Dao County People's Hospital

    Yongzhou, Hunan, 425300, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.